Scientists Decode "Software" Instructions Of Aggressive Leukemia Cells
10/31/2012

Researchers Locate Molecules that Drive the Development of Three Forms of Deadly White Blood Cell Cancers, Pointing Researchers to New Potential Therapeutic Targets A team of national and international researchers, led by Weill Cornell Medical College scientists, have decoded the key "software" instructions that drive three of the most virulent forms of acute lymphoblastic leukemia (ALL)...

Sildenafil Citrate Improves Overall Sexual Function Of Prostate Cancer Patients Receiving Radiation Therapy
10/31/2012

Sildenafil citrate (SC), a phosphodiesterase type 5 inhibitor, administered before, during and after radiation therapy improved overall sexual function of prostate cancer patients, according to research presented today at the American Society for Radiation Oncology's (ASTRO's) 54th Annual Meeting...

Memantine Delays Cognitive Decline In Brain Tumor Patients Who Receive Whole Brain Radiation Therapy
10/31/2012

Memantine, an N-Methyl-D-aspartate receptor antagonist typically prescribed to Alzheimer's patients, slows cognitive decline in brain cancer patients who receive whole brain radiation therapy (WBRT), according to research presented today at the American Society for Radiation Oncology's (ASTRO's) 54th Annual Meeting...

Astrazeneca Begins A New Global Study Of Faslodex® (Fulvestrant) 500 MG Injection In Patients With Hormone Receptor-Positive Advanced Breast Cance
10/31/2012

FALCON (Fulvestrant and AnastrozoLe COmpared in hormonal therapy Naïve advanced breast cancer) trial to compare fulvestrant to anastrozole (ARIMIDEX®) tablets in hormonal therapy-naïve, postmenopausal patients with hormone receptor-positive locally advanced or metastatic breast cancer...

Scientists Decode "Software" Instructions Of Aggressive Leukemia Cells
10/31/2012

Researchers Locate Molecules that Drive the Development of Three Forms of Deadly White Blood Cell Cancers, Pointing Researchers to New Potential Therapeutic Targets A team of national and international researchers, led by Weill Cornell Medical College scientists, have decoded the key "software" instructions that drive three of the most virulent forms of acute lymphoblastic leukemia (ALL)...

Sildenafil Citrate Improves Overall Sexual Function Of Prostate Cancer Patients Receiving Radiation Therapy
10/31/2012

Sildenafil citrate (SC), a phosphodiesterase type 5 inhibitor, administered before, during and after radiation therapy improved overall sexual function of prostate cancer patients, according to research presented today at the American Society for Radiation Oncology's (ASTRO's) 54th Annual Meeting...

Memantine Delays Cognitive Decline In Brain Tumor Patients Who Receive Whole Brain Radiation Therapy
10/31/2012

Memantine, an N-Methyl-D-aspartate receptor antagonist typically prescribed to Alzheimer's patients, slows cognitive decline in brain cancer patients who receive whole brain radiation therapy (WBRT), according to research presented today at the American Society for Radiation Oncology's (ASTRO's) 54th Annual Meeting...

Astrazeneca Begins A New Global Study Of Faslodex® (Fulvestrant) 500 MG Injection In Patients With Hormone Receptor-Positive Advanced Breast Cance
10/31/2012

FALCON (Fulvestrant and AnastrozoLe COmpared in hormonal therapy Naïve advanced breast cancer) trial to compare fulvestrant to anastrozole (ARIMIDEX®) tablets in hormonal therapy-naïve, postmenopausal patients with hormone receptor-positive locally advanced or metastatic breast cancer...

Molecules That Drive The Development Of 3 Forms Of Leukemia Point To New Potential Therapeutic Targets
10/31/2012

A team of national and international researchers, led by Weill Cornell Medical College scientists, have decoded the key "software" instructions that drive three of the most virulent forms of acute lymphoblastic leukemia (ALL)...

Quality Of Life For Men With Prostate Cancer Preserved By Proton Therapy Treatment
10/31/2012

Two studies led by The University of Texas MD Anderson Cancer Center have found that proton therapy preserves the quality of life, specifically urinary and bowel function, in men treated with this targeted radiation modality for prostate cancer. Both studies, led by Andrew K. Lee, M.D., M.P.H...